» Articles » PMID: 2580783

Allospecific T Cell Recognition of HLA-A2 Antigens: Evidence for Group-specific and Subgroup-specific Epitopes

Overview
Journal Immunogenetics
Date 1985 Jan 1
PMID 2580783
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin 2-dependent alloreactive cytotoxic T cell lines, with activity predominantly directed against the HLA-A2 antigen, have been generated in vitro by stimulating blood mononuclear cells from donors nonimmune to the Epstein-Barr (EB) virus with appropriate numbers of EB virus-transformed B cells from A2-homozygous individuals. Such effector cells were tested against a panel of EB virus-transformed target cell lines all expressing the serologically defined A2 antigen but typed into "common A2" and "variant A2" subgroups on the basis of their recognition by A2-restricted EB virus-specific cytotoxic T cells. "Variant A2" responder cells cocultivated with "common A2"-bearing stimulators gave rise to effector T cell lines which recognized only the "common A2"-bearing subgroup of targets. By contrast, responder cells from A2-negative donors stimulated with "common A2"-bearing cells produced effector T cell lines in which the strong lysis of "common A2"-bearing targets was accompanied by a lower, but still significant, lysis directed against all targets within the "variant A2" subgroup. In both cases, lysis of the target cells was blocked equally well by the anti-A2-specific monoclonal antibody MA2.1 as by the monoclonal antibody W6/32 specific for HLA-A, -B, and -C determinants. This suggests that HLA-A2 molecules possess at least two distinct sets of epitopes capable of inducing alloreactive T cell cytotoxicity: first, epitopes probably associated with T cell-restricting sites, which generate subgroup-specific responses, and second, epitopes shared by all A2 molecules, and perhaps associated with serologically defined sites, which generate "pan A2" group-specific responses.

Citing Articles

HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.

Rimando J, Slade M, Dipersio J, Westervelt P, Gao F, Liu C Blood Adv. 2018; 2(24):3590-3601.

PMID: 30563883 PMC: 6306877. DOI: 10.1182/bloodadvances.2018025437.


HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors.

Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz M, Oudshoorn M Biol Blood Marrow Transplant. 2008; 14(9):1064-1071.

PMID: 18721770 PMC: 2572684. DOI: 10.1016/j.bbmt.2008.07.001.


DNA sequences of the genes that encode the CTL-defined HLA-A2 variants M7 and DK1.

Mattson D, Handy D, Bradley D, Coligan J, Cowan E, Biddison W Immunogenetics. 1987; 26(3):190-2.

PMID: 3497874 DOI: 10.1007/BF00365911.


New HLA-A2 variants defined by monoclonal antibodies and cytotoxic T lymphocytes.

Kennedy L, Wallace L, Madrigal J, Rickinson A, Bodmer J Immunogenetics. 1987; 26(3):155-60.

PMID: 3497873 DOI: 10.1007/BF00365905.


Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.

Murray R, Young L, Calender A, Gregory C, Rowe M, Lenoir G J Virol. 1988; 62(3):894-901.

PMID: 2828684 PMC: 253648. DOI: 10.1128/JVI.62.3.894-901.1988.


References
1.
Biddison W, Krangel M, Strominger J, Ward F, Shearer G, Shaw S . Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. Hum Immunol. 1980; 1(3):225-32. DOI: 10.1016/0198-8859(80)90017-8. View

2.
JOYSEY V, Wolf E . HLA-A, -B and -C antigens, their serology and cross-reaction. Br Med Bull. 1978; 34(3):217-22. DOI: 10.1093/oxfordjournals.bmb.a071501. View

3.
Kristensen T, Malissen B, Madsen M, Mawas C . Cloned cytotoxic T lymphocytes. Tissue Antigens. 1981; 18(1):75-8. DOI: 10.1111/j.1399-0039.1981.tb01367.x. View

4.
Rowe M, Hildreth J, Rickinson A, Epstein M . Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity. Int J Cancer. 1982; 29(4):373-81. DOI: 10.1002/ijc.2910290403. View

5.
Moss D, Wallace L, Rickinson A, Epstein M . Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro. Eur J Immunol. 1981; 11(9):686-93. DOI: 10.1002/eji.1830110904. View